Syngo Carbon Clinicals (VA41)
K251059Siemens Healthineers AG · cleared 2025-10-24 · product code QIH · Radiology
Premarket evidence — what FDA accepted
source quote (p.6)
“Syngo Carbon Clinicals is a software only Medical Device, which provides dedicated advanced imaging tools for diagnostic reading.”
source quote (p.12)
“The OrthoMatic Spine core algorithm's outputs for six primary spinal measurements—Cobb angles, coronal balance, kyphosis angle, lordosis angle, and sagittal vertical alignment—were assessed against the mean values obtained from the radiologists' assessments. There is no reader study/bench test that was required for the TimeLens tool as the AI algorithm is very simple workflow enhancement algorithm and the above criteria does not affect the algorithm.”
source quote (p.13)
“The dataset was split into 60% for training, 20% for validation, and 20% for model selection. Splitting was done at the patient level, ensuring no overlap between subsets. Stratification ensured balanced representation across data sources and patient positions. There is no reader study/bench test that was required for the TimeLens tool as the AI algorithm is very simple workflow enhancement algorithm and the above criteria does not affect the algorithm.”
source quote (p.13)
“Siemens Healthcare GmbH conforms to the Cybersecurity requirements by implementing a process of preventing unauthorized access, modifications, misuse or denial of use, or the unauthorized use of information that is stored, accessed, or transferred from a medical device to an external recipient. Contained in this submission are our cybersecurity considerations as they relate to the device Syngo Carbon Clinicals.”
Validation studies (1)
Reader study (MRMC)
n=150 images · 5 site(s)
endpoints: algorithm's measurement deviations fell within the range of inter-reader variability for the major Cobb angle, thoracic kyphosis angle, lumbar lordosis angle, coronal balance, and sagittal vertical alignment
standards: ISO 14971 Third Edition 2019-12, IEC 62304 Edition 1.1 2015-06 CONSOLIDATED VERSION, IEC 82304-1 Edition 1.0 2016-10, IEC 62366-1 Edition 1.1 2020-06 CONSOLIDATED VERSION
Reported performance (0 observations)
FDA source did not state a quantitative performance metric — non-reporting is itself the signal.
Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.
Predicate network
Postmarket — what happened after clearance
Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.
Reimbursement — how devices like this got paid
Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).